Category: Tirzepatide

  • Power of GLP-1 for Drug, Alcohol Addiction, and Binge Eating

    In addition to its use for weight loss and diabetes, there is a growing interest in the potential of GLP-1 receptor agonists for the treatment of various types of addiction, including opioid, cocaine, alcohol, binge eating, and other substance use disorders. While the research is still developing, several studies have suggested that GLP-1 receptor agonists…

    Know More

  • Tirzepatide Research Dosages

    Below are suggested future clinical trial dosages that might be explored for weight loss research based-on studies performed for similar FDA approved GLP-1/GIP products that have already undergone several phases of clinical trials and testing.    *Administered subcutaneously 1x weekly Schedule Weekly Dose in Milligrams (mg) Weekly Dose Converted to Micrograms (mcg) Week 1 –…

    Know More

  • What is Tirzepatide

    Tirzepatide is a novel investigational dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist being developed for the treatment of type 2 diabetes. GIP and GLP-1 are hormones that play crucial roles in regulating blood sugar levels, insulin secretion, and appetite. Tirzepatide works by activating both GIP and GLP-1 receptors,leading to improved glycemic…

    Know More

  • Tirzepatide and Weight Loss

    Tirzepatide is a promising new drug that has shown significant potential in helping individuals achieve weight loss. This drug works by mimicking the action of a hormone called glucagon-like peptide-1 (GLP-1) that regulates appetite and sugar levels in the body. Tirzepatide helps to reduce appetite, increase feelings of fullness, and improve insulin sensitivity, all of…

    Know More